Comment in

• Comment on: excessive opioid use and the development of chronic migraine.

  Bartley J, Watkins LR.Bartley J, et al.Pain. 2009 Sep;145(1-2):262-3. doi: 10.1016/j.pain.2009.06.007. Epub 2009 Jun 23.Pain. 2009.PMID:19553017No abstract available.

Similar articles

• The acute treatment of episodic and chronic migraine in the USA.

  Bigal ME, Borucho S, Serrano D, Lipton RB.Bigal ME, et al.Cephalalgia. 2009 Aug;29(8):891-7. doi: 10.1111/j.1468-2982.2008.01819.x. Epub 2009 Feb 13.Cephalalgia. 2009.PMID:19222509
• Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.

  Holland S, Fanning KM, Serrano D, Buse DC, Reed ML, Lipton RB.Holland S, et al.J Neurol Sci. 2013 Mar 15;326(1-2):10-7. doi: 10.1016/j.jns.2012.12.020. Epub 2013 Feb 8.J Neurol Sci. 2013.PMID:23394974
• [Therapy and prophylaxis of migraine].

  Hoffmann J, Reuter U.Hoffmann J, et al.MMW Fortschr Med. 2009 Apr 2;151(14):114-7; quiz 118.MMW Fortschr Med. 2009.PMID:19504851German.No abstract available.
• Side effects of commonly prescribed analgesic medications.

  Carter GT, Duong V, Ho S, Ngo KC, Greer CL, Weeks DL.Carter GT, et al.Phys Med Rehabil Clin N Am. 2014 May;25(2):457-70. doi: 10.1016/j.pmr.2014.01.007.Phys Med Rehabil Clin N Am. 2014.PMID:24787343Review.
• [Migraine].

  Diener HC, Eikermann A, Pageler L.Diener HC, et al.Fortschr Neurol Psychiatr. 2005 Jan;73(1):44-56; quiz 57-9. doi: 10.1055/s-2004-818409.Fortschr Neurol Psychiatr. 2005.PMID:15666223Review.German.No abstract available.

Cited by

• Opioid Treatment of Migraine: Risk Factors and Behavioral Issues.

  Stone MT, Weed V, Kulich RJ.Stone MT, et al.Curr Pain Headache Rep. 2016 Sep;20(9):51. doi: 10.1007/s11916-016-0581-9.Curr Pain Headache Rep. 2016.PMID:27474093Review.
• PACAP and Other Neuropeptide Targets Link Chronic Migraine and Opioid-induced Hyperalgesia in Mouse Models.

  Anapindi KDB, Yang N, Romanova EV, Rubakhin SS, Tipton A, Dripps I, Sheets Z, Sweedler JV, Pradhan AA.Anapindi KDB, et al.Mol Cell Proteomics. 2019 Dec;18(12):2447-2458. doi: 10.1074/mcp.RA119.001767. Epub 2019 Oct 24.Mol Cell Proteomics. 2019.PMID:31649062Free PMC article.
• Is Medication Overuse Drug Specific or Not? Data from a Review of Published Literature and from an Original Study on Italian MOH Patients.

  Grazzi L, Grignani E, D'Amico D, Sansone E, Raggi A.Grazzi L, et al.Curr Pain Headache Rep. 2018 Aug 27;22(11):71. doi: 10.1007/s11916-018-0729-x.Curr Pain Headache Rep. 2018.PMID:30151604Review.
• Diagnosis and management of migraine in ten steps.

  Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, Pozo-Rosich P, Martelletti P, Ducros A, Lantéri-Minet M, Braschinsky M, Del Rio MS, Daniel O, Özge A, Mammadbayli A, Arons M, Skorobogatykh K, Romanenko V, Terwindt GM, Paemeleire K, Sacco S, Reuter U, Lampl C, Schytz HW, Katsarava Z, Steiner TJ, Ashina M.Eigenbrodt AK, et al.Nat Rev Neurol. 2021 Aug;17(8):501-514. doi: 10.1038/s41582-021-00509-5. Epub 2021 Jun 18.Nat Rev Neurol. 2021.PMID:34145431Free PMC article.Review.
• When pain gets stuck: the evolution of pain chronification and treatment resistance.

  Borsook D, Youssef AM, Simons L, Elman I, Eccleston C.Borsook D, et al.Pain. 2018 Dec;159(12):2421-2436. doi: 10.1097/j.pain.0000000000001401.Pain. 2018.PMID:30234696Free PMC article.Review.

References

Publication types

• Research Support, Non-U.S. Gov't
• Review

MeSH terms

• Analgesics, Opioid / therapeutic use*
• Clinical Trials as Topic*
• Drug-Related Side Effects and Adverse Reactions / epidemiology*
• Humans
• Incidence
• Migraine Disorders / epidemiology*
• Migraine Disorders / prevention & control*
• Prescriptions / statistics & numerical data*
• Risk Assessment / methods*

Substances

• Analgesics, Opioid

Related information

• Cited in Books

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information